Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration

Psychopharmacology

Volumn 142, Issue 4, 1999, Pages 421-425

  Colado, M I ^a   Esteban, B ^a   O'Shea, E ^a   Granados, R ^a   Green, A R ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

'Ecstasy'; 3,4 Methylenedioxymethamphetamine; 5 Hydroxytryptamine; GABA; Hyperthermia; Neurodegeneration; Neuroprotection; Pentobarbitone

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; PAROXETINE; PENTOBARBITAL; SEROTONIN; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; HIPPOCAMPUS; HYPERTHERMIA; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE;

ANIMALS; BODY TEMPERATURE; BRAIN; GAMMA-AMINOBUTYRIC ACID; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPROTECTIVE AGENTS; PAROXETINE; PENTOBARBITAL; RATS;

EID: 0032893307     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050908     Document Type: Article

References (24)

1. A receptor lacking the benzodiazepine modulatory site. Neuropharmacology 32:455-460
2. Busto R, Dietrich WD, Globus MY, Valdos A, Steinberg P, Ginsberg WD (1987) Small differences in intraischemic brain temperature critically determine the extent of ischemic brain injury. J Cereb Blood Flow Metab 7: 729-738
3. Colado MI, Green AR (1994) A study of the mechanism of MDMA ("Ecstasy")-induced neurotoxicity using chlormethiazole, dizocilpine and other protective compounds. Br J Pharmacol 111:131-136
4. Colado MI, Green AR (1995) The spin trap reagent α-phenyl-N-tert-butyl nitrone prevents neurodegeneration following administration of "ecstasy". Eur J Pharmacol 280:343-346
5. Colado MI, Murray TK Green AR (1993) 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br J Pharmacol 108: 583-589
6. Colado MI, O'Shea E, Granados R, Murray TK, Green AR (1997) In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ("ecstasy") and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol 121:889-900
7. Colado MI, O'Shea E, Granados R, Esteban B, Green AR (1998). Role of hyperthermia in the protective effect of clomethiazole against MDMA ("ecstasy")-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR. Br J Pharmacol 124:479-484
8. Corbett D, Evans S, Thomas L, Wang D, Jonas R (1990) MK 801 reduces cerebral ischaemic injury by inducing hypothermia. Brain Res 514:300-304
9. Cross AJ, Jones JA, Baldwin HA, Green AR (1991) Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil. Br J Pharmacol 104:406-411
10. A receptor complex in rat brain. Br J Pharmacol 104:284-289
11. Farfel CM, Seiden LS (1995a) Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments with 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J Pharmacol Exp Ther 272:860-867
12. Farfel CM, Seiden LS (1995b) Role of hypothermia in the mechanism of protection against serotonergic toxicity II. Effects with methamphetamine, p-chloramphetamine, fenfluramine, dizocilpine and dextromethorphan. J Pharmacol Exp Ther 272: 868-875
13. Farfel GM, Vosmer GL, Seiden LS (1992) The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine. Brain Res 595:121-127
14. Green AR (1998) Clomethiazole (Zendra®) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy. Pharmacol Ther 80:123-147
15. Green AR, Cross AJ Goodwin GM (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology 119:247-260
16. A receptor. Neuropharmacology 35:1243-1250
17. A and glycine receptors by chlormethiazole. Eur J Pharmacol 210:239-246
18. Hewitt KE, Green AR (1994) Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ("Ecstasy"). Neuropharmacology 33:1589-1595
19. Malberg JE, Sabol KE, Seiden LS (1996) Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J Pharmacol Exp Ther 278:258-267
20. Molliver ME, Berger UV, Manounas LA, Molliver DL, O'Hearn E, Wilson MA (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann NY Acad Sci 600:640-661
21. Moody EJ, Skolnick P (1989) Chlormethiazole: neurochemical actions at the gamma-aminobutyric acid receptor complex. Eur J Pharmacol 164:153-158
22. Nurse S, Corbett D (1996) Neuroprotection after several days of mild drug-induced hypothermia. J Cereb Blood Flow Metab 16:474-480
23. Small DL, Buchan AM (1997) NMDA antagonists: their role in neuroprotection. In: Green AR, Cross AJ (eds) Neuroprotective agents and cerebral ischaemia. Academic Press, London, pp 137-171
24. A receptors: functional and binding studies. Br J Pharmacol 121:1392-1396